Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by StockinFockeron Dec 07, 2015 6:28pm
201 Views
Post# 24363221

RE:With over 200 people...

RE:With over 200 people...
ElectricFuneral wrote: "By the end of the day, this one will go under .25 because there are no buyer..." - -

OOPS! Looks like CredibilityFuneral would be a more approprate name for this person....  

ElectricFuneral wrote:
who read my supposedly only one post out here, I will add this. I was invested in NPH, last spring, before it took off. Was in at .34 and .38 and got out at .70 the same day it hit the .94 target. Too bad I didn't got out faster at .85 or more. But, I was listening to pumpers like Jimrockford, Leafs67 (with his old trick "always do your DD" ), dart123, CQC master, Of course with Petroknows also..... Dart was saying that it will easily pass the $1,00 mark. I think he mentioned $1,17 or $1,47 at one point. NPH has 4 OTC products for over 2 years and its giving them some extra bucks, that's it. While this one was in the sixties, Arun Nayar sold over 500000 shares, if I'm not mistaken. Eugene Beukman was daytrading a few weeks to make a quick buck (is it sending a good message to quick flip when your an insider? I'll let people answer it by themselves). How come insiders are not buying at these low prices? Probably waiting for their free options, don't you think? With this cream news, it was clear that some investors were gonna get caught again at .29 or more.... I'm glad it was less then 200000 shares. People learn from their previous mistakes I guess..... By the end of the day, this one will go under .25 because there are no buyer + when will be the next news, if the previous one was in October? Waiting over 40 days for a cream.... But, no news about M. Pirooz, the guy who was the owner of pharma. I think he knew what was coming, don't you? Dangerous game with this stock. Ouch....


Bullboard Posts